A Multilevel Study of Eupatorin and Scutellarein as Anti-Amyloid Agents in Alzheimer’s Disease

Today, Alzheimer’s disease (AD)—the most common neurodegenerative disorder, which affects 50 million people—remains incurable. Several studies suggest that one of the main pathological hallmarks of AD is the accumulation of abnormal amyloid beta (Aβ) aggregates; therefore, many therapeutic approache...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizou, Aikaterini E. I., Nasi, Georgia I., Paikopoulos, Yiorgos, Bezantakou, Dimitra S., Vraila, Konstantina D., Spatharas, Panagiotis M., Dimaki, Virginia D., Papandreou, Nikos C., Lamari, Fotini N., Chondrogianni, Niki, Iconomidou, Vassiliki A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216506/
https://www.ncbi.nlm.nih.gov/pubmed/37239029
http://dx.doi.org/10.3390/biomedicines11051357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216506/
https://www.ncbi.nlm.nih.gov/pubmed/37239029
http://dx.doi.org/10.3390/biomedicines11051357

Ejemplares similares